Δημοσίευση στις Aug 2019 στο PubMed: https://pubmed.ncbi.nlm.nih.gov/30882602/?from_term=tsioufis&from_sort=date&from_size=200&from_pos=45

 

Jens Jordan 

 

 

, Alessandra Fanciulli 

, Jens Tank 

 

 

, Giovanna Calandra-Buonaura 

 

, William P Cheshire 

, Pietro Cortelli 

 

, Sabine Eschlboeck 

, Guido Grassi 

 

, Max J Hilz 
0
 

, Horacio Kaufmann 

, Heinz Lahrmann 

, Giuseppe Mancia 

, Gert Mayer 

, Lucy Norcliffe-Kaufmann 

, Anne Pavy-Le Traon 

 

, Satish R Raj 

 

, David Robertson 

, Isabel Rocha 
0
, Hannes Reuter 

 

 

, Walter Struhal 

, Roland D Thijs 

 

, Konstantinos P Tsioufis 

, J Gert van Dijk 

, Gregor K Wenning 

, Italo Biaggioni 

: Supine hypertension commonly occurs in patients with neurogenic orthostatic hypotension due to autonomic failure. Supine hypertension promotes nocturnal sodium excretion and orthostatic hypotension, thus, interfering with quality of life. Perusal of the literature on essential hypertension and smaller scale investigations in autonomic failure patients also suggest that supine hypertension may predispose to cardiovascular and renal disease. These reasons provide a rationale for treating supine hypertension. Yet, treatment of supine hypertension, be it through nonpharmacological or pharmacological approaches, may exacerbate orthostatic hypotension when patients get up during the night. Fall-related complications may occur. More research is needed to define the magnitude of the deleterious effects of supine hypertension on cardiovascular, cerebrovascular, and renal morbidity and mortality. Integration of more precise cardiovascular risk assessment, efficacy, and safety data, and the prognosis of the underlying condition causing autonomic failure is required for individualized management recommendations.

error: